Hetero#39;s COVID-19 oral drug Nirmacom (generic Paxlovid) gets WHO prequalification
Pharma Hetero, a city-based leading pharmaceutical company on Monday announced the receipt of World Health Organisation Prequalification of Medicines Programme (WHO PQ) approval for its generic version of COVID-19 oral anti-viral treatment candidate Nirmatrelvir. A press release from the drug maker said it is the first prequalification for a generic version of Pfizer’s COVID-19 oral […]
Continue Reading